These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 7071030)
21. Shooting for a faster approach to the immunotherapy target: will cluster become conventional? Cox LS Ann Allergy Asthma Immunol; 2009 Mar; 102(3):177-8. PubMed ID: 19354062 [No Abstract] [Full Text] [Related]
23. How does sublingual immunotherapy work? Frew AJ J Allergy Clin Immunol; 2007 Sep; 120(3):533-6. PubMed ID: 17765753 [No Abstract] [Full Text] [Related]
24. Oral routes for immunotherapy: clinical efficacy and kinetics of the allergen. Canonica GW; Passalacqua G; Mariani G; Motta C; Bartolomei M; Mistrello G; Falagiani P; Bagnasco M Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):56-64; discussion 64-7. PubMed ID: 9383892 [No Abstract] [Full Text] [Related]
27. [Hyposensitization: indications and expectations]. Urbanek R Padiatr Padol; 1990; 25(6):397-404. PubMed ID: 2080061 [TBL] [Abstract][Full Text] [Related]
28. [The mechanisms of allergen-specific immunotherapy more clear]. Rak S Lakartidningen; 2008 Jun 25-Jul 1; 105(26-27):1935-7. PubMed ID: 18681375 [No Abstract] [Full Text] [Related]
30. [The value of immunotherapy in treatment of IgE-induced allergic diseases]. Müller UR Ther Umsch; 1994 Jan; 51(1):67-76. PubMed ID: 7511841 [TBL] [Abstract][Full Text] [Related]
31. The efficiency of peptide immunotherapy for respiratory allergy. Incorvaia C; Montagni M; Ridolo E Expert Rev Clin Pharmacol; 2016 Jun; 9(6):831-7. PubMed ID: 26901667 [TBL] [Abstract][Full Text] [Related]
33. Development of polymerized allergens for immunotherapy. Grammer LC; Patterson R Asian Pac J Allergy Immunol; 1983 Jun; 1(1):55-8. PubMed ID: 6681109 [No Abstract] [Full Text] [Related]
34. Are Allergen Immunotherapy Dose Adjustments Needed for Local Reactions, Peaks of Season, or Gaps in Treatment? Epstein TE; Tankersley MS J Allergy Clin Immunol Pract; 2017; 5(5):1227-1233. PubMed ID: 28709818 [No Abstract] [Full Text] [Related]
35. Subcutaneous and sublingual immunotherapy and T regulatory cells: there is clinical relevance. Ciprandi G; Morandi F; Olcese R; Silvestri M; Tosca MA Clin Exp Allergy; 2010 Oct; 40(10):1578-9; author reply 1579-80. PubMed ID: 20937063 [No Abstract] [Full Text] [Related]
36. Modulation of immune responses by immunotherapy in allergic diseases. Cavkaytar O; Akdis CA; Akdis M Curr Opin Pharmacol; 2014 Aug; 17():30-7. PubMed ID: 25062122 [TBL] [Abstract][Full Text] [Related]
37. A review of allergy and allergen specific immunotherapy. Bidad K; Nicknam MH; Farid R Iran J Allergy Asthma Immunol; 2011 Mar; 10(1):1-9. PubMed ID: 21358009 [TBL] [Abstract][Full Text] [Related]
38. A review of allergoid immunotherapy: is cat allergy a suitable target? Nguyen NT; Raskopf E; Shah-Hosseini K; Zadoyan G; Mösges R Immunotherapy; 2016; 8(3):331-49. PubMed ID: 26860435 [TBL] [Abstract][Full Text] [Related]
39. Allergen immunotherapy, routes of administration and cytokine networks: an update. Cuppari C; Leonardi S; Manti S; Filippelli M; Alterio T; Spicuzza L; Rigoli L; Arrigo T; Lougaris V; Salpietro C Immunotherapy; 2014; 6(6):775-86. PubMed ID: 25186606 [TBL] [Abstract][Full Text] [Related]
40. Allergen-specific immunotherapy: current concepts and future directions. Bieber T; Simon HU Allergy; 2011 Jun; 66(6):709-12. PubMed ID: 21518373 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]